Experiences with
Oral chemotherapy17,339 public posts
NICE review of first-line olaparib - your comments needed
Hello All
NICE are undertaking a Cancer Drugs Fund guidance review for olaparib. The name of the NICE consultation is: Olaparib for maintenance treatment of BRCA-mutated ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy (Review of TA598) ID6191
Want to take advantage of all our features? Just log in!
or